1 David Serur, MD, is Medical Director of the Kidney & Pancreas Transplant Program of New York-Presbyterian Hospital/Weill Cornell Medical Center, The Rogosin Institute, NY, NY. Adam Bingaman MD, PhD, is Director of Abdominal Organ Transplantation; Director, Live Donor Kidney Transplant Program; and Director, Renal Transplant Research Program; and also Kidney & Pancreas Transplant Surgeon at Methodist Specialty and Transplant Hospital, San Antonio, TX. Barry Smith, MD, PhD, is President/CEO, The Rogosin Institute, and Professor of Clinical Surgery, Attending Physician, New York-Presbyterian Hospital/ Weill Cornell Medical Center.
Kidney transplantation, whether using organs from deceased or living donors, has been well established as the optimal management for patients with end stage renal disease (ESRD). Unfortunately, it is not nearly as widely available as it should be.
On December 9, 2016, the Rogosin Institute, a full-spectrum kidney care and research organization offering both dialysis and transplantation in New York City, convened a transplant roundtable of 24 experts drawn from multiple sectors from medicine and surgery to media across the United States. Discussants included three individuals who have experienced the benefits of such transplants, one individual waiting for a transplant,